Valuation: Sintx Technologies, Inc.

Market Cap 7.52M 6.52M 6.11M 5.59M 10.55M 716M 10.68M 71.45M 28.04M 358M 28.22M 27.6M 1.19B P/E 2026 *
-0.81x
P/E 2027 * -1.21x
Enterprise Value 7.52M 6.52M 6.11M 5.59M 10.55M 716M 10.68M 71.45M 28.04M 358M 28.22M 27.6M 1.19B EV / Sales 2026 *
3.26x
EV / Sales 2027 * 1.43x
Free-Float
75.59%
Yield 2026 *
-
Yield 2027 * -
1 day-6.32%
1 week+6.54%
Current month-4.12%
1 month-12.83%
3 months-32.08%
6 months-44.56%
Current year-57.77%
1 week 1.51
Extreme 1.51
1.9
1 month 1.4
Extreme 1.4
1.92
Current year 1.4
Extreme 1.4
4.14
1 year 1.4
Extreme 1.4
6.78
3 years 1.4
Extreme 1.4
270
5 years 1.4
Extreme 1.4
30,600
10 years 1.4
Extreme 1.4
10,079,193.66
Manager TitleAgeSince
Chief Executive Officer 63 30/11/2007
President - 15/03/2026
Director of Finance/CFO 41 03/09/2025
Director TitleAgeSince
Director/Board Member 63 30/11/2007
Director/Board Member 63 02/04/2025
Director/Board Member 72 04/11/2012
Date Insider Type Main position Quantity % Market Cap.
23/02/26 Buy

Director

1,000 0.0260%
23/02/26 Buy

Director

8,292 0.2153%
18/02/26 Buy

Director

3,000 0.0779%
Change 5-day change 1-year change 3-year change Capi.($)
-6.32%+6.54%-39.41%-99.37% 7.52M
-0.60%-3.75%-10.66%+17.02% 129B
-0.95%-7.58%-17.91%-2.01% 12.56B
-0.86%+0.93%+92.21%+126.24% 10.08B
-2.47%-1.69%-44.22%-69.67% 4.7B
-0.32%-2.61%-18.80%+36.44% 2.63B
-13.01%-12.46%-0.43%-56.55% 1.74B
-1.60%+18.33%-24.55%-77.71% 1.74B
-1.64%-2.34%-18.12%-19.73% 1.67B
Average -3.12%+1.96%-9.10%-16.15% 18.27B
Weighted average by Cap. -0.90%-3.71%-6.11%+17.94%

Financials

2026 *2027 *
Net sales 2.3M 2M 1.87M 1.71M 3.23M 219M 3.27M 21.9M 8.59M 110M 8.65M 8.46M 365M 5.27M 4.57M 4.28M 3.92M 7.39M 502M 7.49M 50.07M 19.65M 251M 19.78M 19.35M 834M
Net income -12.38M -10.74M -10.06M -9.2M -17.37M -1.18B -17.6M -118M -46.18M -589M -46.48M -45.47M -1.96B -11.38M -9.87M -9.24M -8.46M -15.96M -1.08B -16.17M -108M -42.44M -541M -42.71M -41.79M -1.8B
Net Debt - -
Logo Sintx Technologies, Inc.
SINTX Technologies, Inc. is an advanced ceramics company that develops and commercializes materials, components, and technologies for medical and agribiotech applications. It is engaged in the research, development, and manufacturing of silicon nitride. Its core business includes biomedical applications and antipathogenic applications. It has been focused on medical grade silicon nitride. Spinal implants made from its silicon nitride have been implanted in humans. This established use, along with its inherent resistance to bacterial adhesion and bone affinity suggests that it may also be suitable in other fusion device applications such as arthroplasty implants, foot wedges, and dental implants. Its composition of silicon nitride antipathogenic powder may enable manufacturing surfaces that inactivate pathogens, thereby limiting the spread of infection and disease. It manufactures advanced ceramic powders and components in its manufacturing facilities based in Salt Lake City, Utah.
Employees
32
Date Price Change Volume
06/08/26 US$1.630 -6.32% 14,365
05/08/26 US$1.740 +4.82% 33,306
04/08/26 US$1.660 -6.21% 28,157
03/08/26 US$1.770 +4.12% 43,667
31/07/26 US$1.700 +11.11% 28,787
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1.740USD
Average target price
9.125USD
Spread / Average Target
+424.43%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SINT Stock